Psychometric properties of the Chinese version of the Functional Assessment of Cancer Therapy-Cervix (FACT-Cx) measuring health-related quality of life

Health and Quality of Life Outcomes

Ingalill R Hallberg¹  Yan Hu²  Yan Ding³ 

[1] Department of Health Sciences, Lund University, Baravägen 3, Lund, SE-22100, Sweden;Nursing School, Fudan University, No. 305 Feng Lin Road, Shanghai, 200032, China;Nursing Department, Obstetrics and Gynecology Hospital of Fudan University, No. 419 Fang Xie Road, Shanghai, 200011, China

关键词: Cervical cancer;    Psychometric properties;    Chinese version;    FACT-G;    FACT-Cx;    Health-related quality of life;   

Others  :  825020
DOI  :  10.1186/1477-7525-10-124

 received in 2012-03-22, accepted in 2012-09-28,  发布年份 2012

【 摘 要 】

Background

The Functional Assessment of Cancer Therapy (FACT) is one of the most commonly used self-report instruments for evaluation of health-related quality of life in oncology patients. However, cultural considerations necessitate testing of the subscales in different populations. We sought to qualitatively and quantitatively investigate the applicability and psychometric properties of the Chinese version of the FACT-Cervix (FACT-Cx) in Chinese women with cervical cancer.

Methods

Ten personal interviews were conducted in order to explore patients’ opinions about the scale and its items in depth. In addition the questionnaire was administered to 400 women with cervical cancer to test its psychometric properties. Reliability was assessed using Cronbach’s alpha coefficient and item-subscale correlation while validity was evaluated using factor analysis and known-group validity.

Results

Some items related to sex and the ability to give birth were questioned in the personal interviews, mostly regarding their significance and acceptance in the Chinese cultural context. The Cronbach’s alphas of FACT-Cx and the subscales were greater than 0.7, except for the cervical-cancer-specific subscale which was 0.57. Factor analysis demonstrated that the FACT-G construct generally paralleled the original. There were significant differences in the FACT-Cx and some subscales between those receiving and not receiving treatment and among the patients with different performance status.

Conclusions

In general, psychometric properties of the Chinese version supported its use with cervical cancer patients in Mainland China. Further work is needed to improve the psychometric adequacy of the cervical-cancer-specific subscale and adjust it to cultural considerations.

【 授权许可】

   
2012 Ding et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]WHO/ICO: Information Centre on HPV and Cervical Cancer (HPV Information Centre). Human Papillomavirus and Related Cancers in Asia. Summary Report 2010. [Date accessed]. Available at www.who.int/hpvcentre webcitehttp://apps.who.int/hpvcentre/statistics/dynamic/ico/country_pdf/XSX.pdf?CFID=6770532&CFTOKEN=98832658 webcite.
• [2]Cella DF: Quality of life: concepts and definition. J Pain Symptom Manage 1994, 9(3):186-192.
• [3]Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, Silberman M, Yellen SB, Winicour P, Brannon J, et al.: The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol 1993, 11(3):570-579.
• [4]Boling W, Fouladi RT, Basen-Engquist K: Review Article Health-related quality of life in gynecological oncology: Instruments and psychometric properties. Int J Gynecol Cancer 2003, 13(1):5-14.
• [5]Cella DF, Bonomi AE, Lloyd SR, Tulsky DS, Kaplan E, Bonomi P: Reliability and validity of the Functional Assessment of Cancer Therapy-Lung (FACT-L) quality of life instrument. Lung Cancer 1995, 12(3):199-220.
• [6]Winstead-Fry P, Schultz A: Psychometric analysis of the Functional Assessment of Cancer Therapy-General (FACT-G) scale in a rural sample. Cancer 1997, 79(12):2446-2452.
• [7]Janda M, Obermair A, Cella D, Perrin LC, Nicklin JL, Ward BG, Crandon AJ, Trimmel M: The functional assessment of cancer-vulvar: reliability and validity. Gynecol Oncol 2005, 97(2):568-575.
• [8]Basen-Engquist K, Bodurka-Bevers D, Fitzgerald MA, Webster K, Cella D, Hu S, Gershenson DM: Reliability and validity of the functional assessment of cancer therapy-ovarian. J Clin Oncol 2001, 19(6):1809-1817.
• [9]Chen YC: Chinese values, health and nursing. J Adv Nurs 2001, 36(2):270-273.
• [10]Zeng YC, Ching SS, Loke AY: Quality of life measurement in women with cervical cancer: implications for Chinese cervical cancer survivors. Health Qual Life Outcomes 2011, 8:30.
• [11]Yu CL, Fielding R, Chan CL, Tse VK, Choi PH, Lau WH, Choy DT, Choy DT, O SK, Lee AW, Sham JS: Measuring quality of life of Chinese cancer patients: A validation of the Chinese version of the Functional Assessment of Cancer Therapy-General (FACT-G) scale. Cancer 2000, 88(7):1715-1727.
• [12]Wan C, Meng Q, Tang X: to evaluation of the Chinese version of FACT-G among Chinese cancer patients. J Practi Oncol 2006, 21:77-80.
• [13]Wan C, Zhang C, Cai L, Tu X, Feng C, Luo J, Zhang X: Psychometric properties of the Chinese version of the FACT-L for measuring quality of life in patients with lung cancer. Lung Cancer 2007, 56(3):415-421.
• [14]Wan C, Zhang D, Yang Z, Tu X, Tang W, Feng C, Wang H, Tang X: Validation of the simplified Chinese version of the FACT-B for measuring quality of life for patients with breast cancer. Breast Cancer Res Treat 2007, 106(3):413-418.
• [15]Monk BJ, Huang HQ, Cella D, Long HJ 3rd: Quality of life outcomes from a randomized phase III trial of cisplatin with or without topotecan in advanced carcinoma of the cervix: a Gynecologic Oncology Group Study. J Clin Oncol 2005, 23(21):4617-4625.
• [16]Eremenco SL, Cella D, Arnold BJ: A comprehensive method for the translation and cross-cultural validation of health status questionnaires. Eval Health Prof 2005, 28(2):212-232.
• [17]Streiner DL, Norman GR: Health measurement scales: a practical guide to their development and use. 3rd edition. Oxford: Oxford University Press; 2003.
• [18]Walters SJ: quality of life outcomes in clinical trials and health-care evaluation: a practical guide to analysis and interpretation. Chichester: John Wiley & Sons Ltd; 2009.
• [19]Hair JF: Multivariate data analysis. 6th edition. Upper Saddle River, N.J.: Pearson Prentice Hall; 2006.
• [20]Fang JQ: Public health statistics. Beijing: People's health press; 2003.
• [21]Healey JF: Statistics: a tool for social research. 6th edition. Belmont, CA: Wadsworth, Thomson Learning; 2002.
• [22]Hair JF: Multivariate data analysis: a global perspective. 7th edition. Upper Saddle River, N.J: Pearson Education; 2010.
• [23]Polit DF, Beck CT: Nursing research: principles and methods. 7th edition. Philadelphia: Lippincott Williams & Wilkins; 2004.
• [24]Basen-Engquist K, Paskett ED, Buzaglo J, Miller SM, Schover L, Wenzel LB, Bodurka DC: Cervical cancer. Cancer 2003, 98(9 Suppl):2009-2014.
• [25]Schover LR, Fife M, Gershenson DM: Sexual dysfunction and treatment for early stage cervical cancer. Cancer 1989, 63(1):204-212.
• [26]Wenzel L, DeAlba I, Habbal R, Kluhsman BC, Fairclough D, Krebs LU, Anton-Culver H, Berkowitz R, Aziz N: Quality of life in long-term cervical cancer survivors. Gynecol Oncol 2005, 97(2):310-317.
• [27]Tang C, Siu B, Lai F, Chung T: Heterosexual Chinese women's sexual asjustment after gynecologic cancer. J Sex Res 1996, 33:189-195.
• [28]Ding Y, Zhu YL, Zhang MF: Quality of life of Chinese patients with ovarian malignancies during chemotherapy under condition of no recurrence. Cancer Nurs 2007, 30(3):243-251.
• [29]Zeng YC, Li D, Loke AY: Life after cervical cancer: quality of life among Chinese women. Nurs Health Sci 2011, 13(3):296-302.
• [30]Park SY, Bae DS, Nam JH, Park CT, Cho CH, Lee JM, Lee MK, Kim SH, Park SM, Yun YH: Quality of life and sexual problems in disease-free survivors of cervical cancer compared with the general population. Cancer 2007, 110(12):2716-2725.